Transmucosal fentanyl (Actiq): For breakthrough cancer pain - 11/2018
Transmucosal fentanyl (Actiq): For breakthrough cancer pain
Abstract
This handout explains what patients need to know when their doctor prescribes transmucosal fentanyl (brand name Actiq) for cancer pain.
Publisher
University of Washington Medical Center
Date Published (original date)
2018
Revision Date
11/2018
General Subject
Cancer
Specific Subject/Keyword
Pain Management
Medicine Information
Pain
Languages
English
Record ID
4713